EATON CORP PLC
ETNNYSE🏆 #98 by market capEarnings Nov 3 · PreUS Equity
$392.88▲ $8.68 (+2.26%)
🌙 After hours$391.94▼ 0.24%Regular close · extended-hours price shownTrack ETN
Get earnings, price moves & breaking news on Telegram
24h▲ 2.3%
7d▼ 0.2%
14d▼ 3.9%
30d▼ 8.9%
ytd▲ 23.4%
1y▲ 4.6%
🏦Market Cap
$152.59B
Mid Cap
📈Revenue Growth (YoY)
15.5%
Healthy
📊Gross Margin
35.9%
Healthy
💵FCF Margin
13.1%
Healthy
⚖️P/S Ratio
4.9x
Fair
Otter Score
68
Fair
EATON CORP PLC
ETNAnalyst Ratings
Price
$392.88
Total
40
Raised
8
Lowered
8
Avg PT
$502.38
H / L
$520 / $480
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
RBC Capital | Reiterated | Outperform | 2026-10-14 | $512.00 | +30.30% |
Citigroup | Reiterated | Buy | 2026-10-12 | $348.00 | −11.40% |
UBS | Upgraded | Neutral → Buy | 2026-09-08 | $515.00 | +31.10% |
Morgan Stanley | Reiterated | Overweight | 2026-08-28 | $520.00 | +32.40% |
Evercore ISI Group | Reiterated | Outperform | 2026-08-11 | — | — |
BMO Capital | Reiterated | Outperform | 2026-08-03 | $487.00 | +24.00% |
Keybanc | Reiterated | Overweight | 2026-05-06 | $480.00 | +22.20% |
Barclays | Reiterated | Equal Weight | 2026-05-06 | $350.00 | −10.90% |
Wells Fargo | Reiterated | Equal Weight | 2026-05-06 | $503.00 | +28.00% |
JP Morgan | Reiterated | Overweight | 2026-05-06 | $145.00 | −63.10% |
HSBC | Upgraded | Hold → Buy | 2026-01-16 | $400.00 | +1.80% |
Wolfe Research | Upgraded | Peer Perform → Outperform | 2025-12-09 | $413.00 | +5.10% |
Mizuho | Reiterated | Outperform | 2025-10-17 | — | — |
Melius Research | Upgraded | Hold → Buy | 2025-09-15 | $495.00 | +26.00% |
Raymond James | Reiterated | Outperform | 2025-08-07 | $415.00 | +5.60% |
Goldman Sachs | Reiterated | Buy | 2025-07-08 | $146.00 | −62.80% |
Jefferies | Reiterated | Buy | 2025-03-12 | $385.00 | −2.00% |
B of A Securities | Reiterated | Buy | 2024-11-13 | — | — |
Argus Research | Reiterated | Buy | 2024-05-02 | $185.00 | −52.90% |
Berenberg | Reiterated | Buy | 2024-03-06 | — | — |
Deutsche Bank | Reiterated | Buy | 2023-04-12 | $156.00 | −60.30% |
Oppenheimer | Downgraded | Outperform → Perform | 2022-12-06 | $170.00 | −56.70% |
Credit Suisse | Reiterated | Outperform | 2022-11-02 | $167.00 | −57.50% |
KeyBanc | Downgraded | Overweight → Sector Weight | 2020-05-14 | $480.00 | +22.20% |
Stephens & Co. | Downgraded | Overweight → Equal Weight | 2020-05-04 | — | — |
Gordon Haskett | Upgraded | Hold → Buy | 2020-04-03 | — | — |
Vertical Research | Upgraded | Hold → Buy | 2020-02-06 | — | — |
Baird | Reiterated | Neutral | 2020-02-05 | — | — |
Bank of America | Upgraded | Neutral → Buy | 2019-12-17 | — | — |
Vertical Group | Downgraded | Buy → Hold | 2019-10-09 | — | — |
Argus | Reiterated | Buy | 2018-05-05 | — | — |
Stifel | Reiterated | Buy | 2018-05-03 | — | — |
Stifel Nicolaus | Reiterated | Buy | 2018-05-03 | — | — |
Longbow Research | Upgraded | Neutral → Buy | 2017-04-04 | — | — |
Buckingham Research | Reiterated | Neutral | 2016-05-02 | — | — |
Bernstein | Reiterated | Market Perform | 2016-05-02 | $295.00 | −24.90% |
Standpoint Research | Downgraded | Buy → Hold | 2016-02-17 | — | — |
William Blair | Downgraded | Outperform → Neutral | 2015-10-15 | — | — |
MKM Partners | Downgraded | Buy → Neutral | 2014-02-05 | — | — |
ISI Group | Downgraded | Strong Buy → Buy | 2013-08-09 | — | — |
Institution
RBC Capital
Reiterated · Outperform · 2026-10-14
$512.00
+30.30%
Citigroup
Reiterated · Buy · 2026-10-12
$348.00
−11.40%
UBS
Upgraded · Neutral → Buy · 2026-09-08
$515.00
+31.10%
Morgan Stanley
Reiterated · Overweight · 2026-08-28
$520.00
+32.40%
Evercore ISI Group
Reiterated · Outperform · 2026-08-11
—
—
BMO Capital
Reiterated · Outperform · 2026-08-03
$487.00
+24.00%
Keybanc
Reiterated · Overweight · 2026-05-06
$480.00
+22.20%
Barclays
Reiterated · Equal Weight · 2026-05-06
$350.00
−10.90%
Wells Fargo
Reiterated · Equal Weight · 2026-05-06
$503.00
+28.00%
JP Morgan
Reiterated · Overweight · 2026-05-06
$145.00
−63.10%
HSBC
Upgraded · Hold → Buy · 2026-01-16
$400.00
+1.80%
Wolfe Research
Upgraded · Peer Perform → Outperform · 2025-12-09
$413.00
+5.10%
Mizuho
Reiterated · Outperform · 2025-10-17
—
—
Melius Research
Upgraded · Hold → Buy · 2025-09-15
$495.00
+26.00%
Raymond James
Reiterated · Outperform · 2025-08-07
$415.00
+5.60%
Goldman Sachs
Reiterated · Buy · 2025-07-08
$146.00
−62.80%
Jefferies
Reiterated · Buy · 2025-03-12
$385.00
−2.00%
B of A Securities
Reiterated · Buy · 2024-11-13
—
—
Argus Research
Reiterated · Buy · 2024-05-02
$185.00
−52.90%
Berenberg
Reiterated · Buy · 2024-03-06
—
—
Deutsche Bank
Reiterated · Buy · 2023-04-12
$156.00
−60.30%
Oppenheimer
Downgraded · Outperform → Perform · 2022-12-06
$170.00
−56.70%
Credit Suisse
Reiterated · Outperform · 2022-11-02
$167.00
−57.50%
KeyBanc
Downgraded · Overweight → Sector Weight · 2020-05-14
$480.00
+22.20%
Stephens & Co.
Downgraded · Overweight → Equal Weight · 2020-05-04
—
—
Gordon Haskett
Upgraded · Hold → Buy · 2020-04-03
—
—
Vertical Research
Upgraded · Hold → Buy · 2020-02-06
—
—
Baird
Reiterated · Neutral · 2020-02-05
—
—
Bank of America
Upgraded · Neutral → Buy · 2019-12-17
—
—
Vertical Group
Downgraded · Buy → Hold · 2019-10-09
—
—
Argus
Reiterated · Buy · 2018-05-05
—
—
Stifel
Reiterated · Buy · 2018-05-03
—
—
Stifel Nicolaus
Reiterated · Buy · 2018-05-03
—
—
Longbow Research
Upgraded · Neutral → Buy · 2017-04-04
—
—
Buckingham Research
Reiterated · Neutral · 2016-05-02
—
—
Bernstein
Reiterated · Market Perform · 2016-05-02
$295.00
−24.90%
Standpoint Research
Downgraded · Buy → Hold · 2016-02-17
—
—
William Blair
Downgraded · Outperform → Neutral · 2015-10-15
—
—
MKM Partners
Downgraded · Buy → Neutral · 2014-02-05
—
—
ISI Group
Downgraded · Strong Buy → Buy · 2013-08-09
—
—
One row per institution · price target from the firm's latest published target